← Open Payments lookup

KRISTEN BEVILL: Open Payments

NPI 1841315546 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,156 in 125 payments from 20 companies in 2025. Trend: 2023 $2,019 · 2024 $1,793 · 2025 $2,156

Food & beverage: $2,156
CompanyPaymentsAmount
Lundbeck LLC29$474
Janssen Pharmaceuticals, Inc11$251
Otsuka America Pharmaceutical, Inc.23$249
ABBVIE INC.12$173
Takeda Pharmaceuticals U.S.A., Inc.8$151
Teva Pharmaceuticals USA, Inc.7$143
Axsome Therapeutics, Inc.8$139
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$133
Neurocrine BioSciences, Inc.5$98
E.R. Squibb & Sons, L.L.C.5$85

Products named: REXULTI, ABILIFY ASIMTUFII, SPRAVATO, VRAYLAR, TRINTELLIX, UZEDY, Auvelity, CAPLYTA.

Industry payments across MS — which companies pay providers there.